impact of met inhibitors in met exon 14-mutant nsclc
Published 7 years ago • 639 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
1:02
investigating met exon 14 mutations in patients with nsclc
-
3:35
the availability of met inhibitors for nsclc
-
1:17
updates on met targeted therapy for exon 14 mutations in lung cancer | oncotarget
-
3:01
update from chrysalis: amivantamab in patients with nsclc with met exon 14 skipping mutation
-
0:58
vision trial produces positive data in nsclc with met exon 14 mutations
-
1:11
detecting the met exon 14 skipping mutations in nsclc
-
2:51
impaired c-met receptor degradation mediated by met exon 14 mutations in non–small-cell lung cancer
-
1:33:47
oncology cancer treatment update - 23 aug 2024
-
8:04
fda priority review of capmatinib for metex14-mutated nsclc
-
13:06
met exon 14 mutations in mnsclc
-
1:18
amivantamab for nsclc with met exon 14 skipping mutations
-
0:45
dr. gregory riely on potential treatment for patients with met exon 14 mutation
-
6:13
vision: tepotinib in met exon 14 skipping nsclc
-
1:06
gregory j. riely provides an overview of met exon 14 skipping mutations in lung cancer
-
1:37
dr. awad on acquired resistance to met inhibitors in nsclc
-
3:24
off-label crizotinib for the treatment of metex14-mutated nsclc
-
3:40
metex14 sas (met exon 14 skipping alterations) in non-small cell lung cancer
-
1:36
met as a clinical target in lung cancer
-
4:08
targeted therapies in lung cancer